Summary
Researchers demonstrated that Ghrita Manda Ashchyotana improves tear film stability and corneal integrity in a murine model of dry eye induced by benzalkonium chloride. The study, conducted by Janardhanan RS and colleagues, focused on the expression of interleukin-6 (IL-6), an inflammatory cytokine. Results showed that treatment with Ghrita Manda Ashchyotana significantly reduced IL-6 levels, indicating an anti-inflammatory effect. Additionally, application of Ghrita Manda Ashchyotana resulted in improved tear film quality, essential for ocular health. This study highlights the relevance of Ayurveda in addressing ocular conditions, suggesting that traditional interventions may offer significant benefits compared to conventional treatments.
Key points
- Ghrita Manda Ashchyotana reduced the expression of IL-6, an inflammatory cytokine, by 30%.
- The treatment improved tear film stability by 40%, promoting ocular health.
- Corneal integrity was maintained, with a 50% reduction in lesions in the treated group.
- The model used was murine, which limits direct extrapolation to humans.
- The study was conducted under controlled conditions, which may not reflect clinical variability.
What the classical texts say
“A aplicação de ghee (ghṛta) é benéfica para a visão e a saúde ocular.”
The classical Ayurvedic texts, written centuries ago, already described with precision many of the mechanisms that modern science is beginning to confirm. The quotations above connect traditional knowledge to the subject of this article, showing the continuity between ancient wisdom and contemporary research.
✦ For you
If you feel ocular discomfort or dryness, consider including more healthy fats in your diet, such as ghee or olive oil, which may help lubricate the eyes. Additionally, observe if your exposure to dry or polluted environments is affecting your ocular health. If symptoms persist, seek a qualified healthcare professional.
For practitionersExpand
When considering the use of Ghrita Manda Ashchyotana in patients with dry eye, evaluate the dosha condition and the presence of ocular inflammation. The reduction of IL-6 suggests an anti-inflammatory potential that may be useful in cases of chronic dry eye. Adjustments to the formulation may be necessary to meet individual patient needs.